BioSpace News Archive

Policy

U.S. FDA Grants Orphan Drug Designation (ODD) for Quilience(R) (Mazindol ER) for the Treatment of Idiopathic Hypersomnia (IH)

NLS Pharmaceutics Ltd. announces that it has received Orphan Drug Designation from the FDA in the United States for Mazindol, the active ingredient in its lead product candidate, Quilience® for the treatment of Idiopathic Hypersomnia.

November 2, 2022
·
6 min read
Biotech Beach

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on November 9, 2022

Regen BioPharma, Inc. (OTC-PINK: RGBP) (OTC-PINK: RGBPP) will be presenting at the Emerging Growth Conference on November 9, 2022 (https://emerginggrowth.com/conference/).

November 2, 2022
·
3 min read
Bio NC

BPL Supports the Immune Deficiency Foundation Research Grant Program for Second Year in a Row

Bio Products Laboratory, a leading manufacturer of plasma-derived protein therapies with US Offices in Durham, NC, announced its support of the Immune Deficiency Foundation Research Grant Program for the second year in a row.

November 2, 2022
·
3 min read
Biotech Beach

Viracta Therapeutics to Present at Upcoming November 2022 Investor Conferences

Viracta Therapeutics, Inc. announced that company leadership is scheduled to present and participate in one-on-one meetings at four investor conferences in November.

November 2, 2022
·
2 min read
Biotech Bay

Amgen to Webcast Investor Call at AHA 2022

Amgen will host a webcast call for the investment community in conjunction with the American Heart Association Scientific Sessions at 6:00 p.m. ET on Monday, Nov. 7, 2022.

November 2, 2022
·
2 min read